RxSight, Inc. (RXST) Tops Q3 EPS by 24c

RxSight, Inc. (NASDAQ: RXST) reported Q3 EPS of ($0.19), $0.24 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $22.2 million versus the consensus estimate of $20.55 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral
• BlackRock’s Rosenberg says inflation data key after jobs beat